Li Texin, Fountain Betty L, Duffy Edward W
Department of Radiation Oncology, Tuomey Healthcare System, Sumter, SC 29150, USA.
Brachytherapy. 2010 Apr-Jun;9(2):159-64. doi: 10.1016/j.brachy.2009.08.008. Epub 2009 Oct 22.
To investigate the dosimetric effect of planning margin in (131)Cs prostate seed implants.
The transrectal ultrasonography images are obtained intraoperatively in 5-mm steps from base to apex. The prostate is contoured as clinical target volume (CTV). The CTV is enlarged with 3mm expansion except the posterior. The CTV and planning target volume (PTV) are then used as planning target for treatment planning, respectively. Dose calculations are performed using VariSeed treatment planning system using AAPM TG-43 formalism. The total activity implanted, target coverage (the percent of the prostate volume covered by the prescription dose, V(100); the dose that covers 90% of the prostate volume, D(90)) for CTV and PTV, dose inhomogeneity (the percentage volume of the prostate receiving 150% of the prescription dose [V(150)]), and the critical organ dose (the dose that covers 10% of the urethra volume [UD(10)] for urethra and the dose that covers 50% of the rectum volume [RD(50)] for rectum) are compared.
When CTV is used as target for planning, compared with PTV as planning target, the total activity implanted is decreased by 5.6%. Integral dose is thus lower by 5.6%. Coverage for CTV (CTV(100)) is increased by 0.3%. Coverage for PTV (PTV(100)) is lower by 2.1%. CTV(150) is increased by 13.6%. PTV(150) is higher by 2.5% with a standard deviation of 10.2%. Rectum dose (RD(50)) is lower by 4.5%. Urethra dose (UD(10)) is higher by 10.0%.
It is shown that the planning margin has minimal effect on dosimetric quality because of (131)Cs's gradual dose fall-off. Thus, it is possible to reduce or even eliminate planning margin using (131)Cs. The modest benefits in reducing the planning margin, such as lower total activity (lower integral dose), dose reduction to surrounding healthy tissues and reduced likelihood of seeds migration, can be achieved while adequate coverage is maintained.
研究¹³¹Cs前列腺籽源植入中计划靶区边缘的剂量学效应。
术中经直肠超声图像从前列腺底部到尖部以5mm步长获取。前列腺轮廓勾画为临床靶区(CTV)。除后部外,CTV向各个方向均匀外放3mm形成计划靶区(PTV)。然后将CTV和PTV分别用作治疗计划的计划靶区。使用VariSeed治疗计划系统,依据美国医学物理师协会(AAPM)TG - 43形式主义进行剂量计算。比较植入的总活度、CTV和PTV的靶区覆盖情况(处方剂量覆盖的前列腺体积百分比,V(100);覆盖90%前列腺体积的剂量,D(90))、剂量不均匀性(接受150%处方剂量的前列腺体积百分比[V(150)])以及危及器官剂量(覆盖10%尿道体积的剂量[UD(10)]用于尿道,覆盖50%直肠体积的剂量[RD(50)]用于直肠)。
当以CTV作为计划靶区时,与以PTV作为计划靶区相比,植入的总活度降低了5.6%。积分剂量因此降低了5.6%。CTV的覆盖度(CTV(100))增加了0.3%。PTV的覆盖度(PTV(100))降低了2.1%。CTV(150)增加了13.6%。PTV(150)高2.5%(标准差为10.2%)。直肠剂量(RD(50))降低了4.5%。尿道剂量(UD(10))高10.0%。
结果表明,由于¹³¹Cs剂量的逐渐下降,计划靶区边缘对剂量学质量影响极小。因此,使用¹³¹Cs有可能减少甚至消除计划靶区边缘。在保持足够覆盖度的同时,可以实现减少计划靶区边缘带来的适度益处,如降低总活度(降低积分剂量)、减少对周围健康组织的剂量以及降低籽源迁移的可能性。